Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up

Abstract

Background: Different treatment approaches aimed at reducing attention-deficit/hyperactivity disorder (ADHD) core symptoms are available. However, factors such as intolerance, side-effects, lack of efficacy, high new technology costs, and placebo effect have spurred on an increasing interest in alternative or complementary treatment.

Aim: The aim of this study is to explore efficacy of multimodal treatment consisting of standard stimulant medication (methylphenidate) and neurofeedback (NF) in combination, and to compare it with the single treatment in 6-month follow-up in ADHD children and adolescents.

Methods: This randomized controlled trial with 6-month follow-up comprised three treatment arms: multimodal treatment (NF + MED), MED alone, and NF alone. A total of 130 ADHD children/adolescents participated, and 62% completed the study. ADHD core symptoms were recorded pre-/post-treatment, using parents’ and teachers’ forms taken from Barkley’s Defiant Children: A Clinician’s Manual for Assessment and Parent Training, and a self-report questionnaire.

Results: Significant ADHD core symptom improvements were reported 6 months after treatment completion by parents, teachers, and participants in all three groups, with marked improvement in inattention in all groups. However, no significant improvements in hyperactivity or academic performance were reported by teachers or self-reported by children/adolescents, respectively, in the three groups. Changes obtained with multimodal treatment at 6-month follow-up were comparable to those with single medication treatment, as reported by all participants.

Conclusions: Multimodal treatment using combined stimulant medication and NF showed 6-month efficacy in ADHD treatment. More research is needed to explore whether multimodal treatment is suitable for ADHD children and adolescents who showed a poor response to single medication treatment, and for those who want to reduce the use of stimulant medication.

Keywords:

• ADHD
• medication
• neurofeedback
• multimodal treatment
• self-report

Acknowledgements

We are grateful to all participants and their families who took part in this clinical study. We thank the Child and Adolescent Psychiatry Department of Helse Fonna Hospital Haugesund, Helse Fonna Trust Haugesund, Norway for its support in completing this study.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The authors received no financial support for the research or authorship of this article. Trial registration: NCT01252446 Current Controlled Trials.

Additional information

Funding

We thank the Child and Adolescent Psychiatry Department of Helse Fonna Hospital Haugesund, Helse Fonna Trust Haugesund, Norway for its support in completing this study.